Research Alliance Corporation III filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 16, 2026, covering results from its February 19, 2026 inception through that date.

Key Highlights

  • Net loss of $1,950,387 was recorded for the three months ended September 30, 2026, according to the filing.
  • Trust Account balance of $75,953,273 in marketable securities was held as of September 30, 2026, with 7,500,000 Class A ordinary shares subject to possible redemption at $10.13 per share.
  • Total assets of $78,898,015 were reported on the September 30, 2026 balance sheet.
  • Total shareholders' deficit of $(3,902,110) and accumulated deficit of $(3,902,270) were reported as of September 30, 2026.
  • IPO proceeds of $75,000,000 were deposited into the Trust Account, with an additional $2,750,000 raised from the sale of Private Placement Shares, the filing disclosed.
  • Backstop liability of $1,687,399 was recognized, following an initial fair value upon recognition of $(2,176,798) and a subsequent change in fair value of $489,399.
  • 7,775,000 Class A and 1,323,529 Class B ordinary shares were issued and outstanding as of November 10, 2026, per the filing.

Research Alliance Corporation III Financial Results for the Period Ended September 30, 2026

Research Alliance Corporation III (NASDAQ:RACC), a blank check company incorporated in the Cayman Islands with offices at 600 Fifth Avenue, 23rd Floor, New York, NY 10020, reported a net loss of $1,950,387 for the three months ended September 30, 2026, and a net loss of $1,961,586 for the period from February 19, 2026 (inception) through September 30, 2026, according to the filing. The company reported general, formation and administrative expenses of $977,793 for the quarter and $1,227,460 since inception.

The filing disclosed that the company completed its Initial Public Offering, depositing $75,000,000 into a Trust Account, which held $75,953,273 in marketable securities as of September 30, 2026, reflecting $953,273 in interest earned since inception. The 7,500,000 Class A ordinary shares subject to possible redemption were carried at a redemption value of $10.13 per share. Outside the Trust, the company reported cash of $183,405 and total current assets of $312,054 against current liabilities of $2,909,453, which included $2,526,142 in accrued offering costs.

The filing also noted a deferred underwriting fee payable of $2,250,000 and a backstop liability of $1,687,399 as of the balance sheet date. Basic and diluted net loss per Class A ordinary share subject to redemption was $(0.21) for the quarter and $(0.33) for the period from inception, based on weighted average shares of 7,500,000 and 4,453,125, respectively. The registrant identified itself as a shell company, a smaller reporting company, and an emerging growth company.

What Was Disclosed

Research Alliance Corporation III disclosed its unaudited financial statements for the period from February 19, 2026 (inception) through September 30, 2026, including a net loss of $1,961,586 since inception, a Trust Account balance of $75,953,273, and a total shareholders' deficit of $(3,902,110).